Radiolabeling and In-Silico Study of 131I-(4-fluorobenzoyl-3-methylthiourea) as Radiopharmaceuticals for Breast Cancer Theranostics. (2024). Jurnal Kimia Valensi, 10(1), 27-44. https://doi.org/10.15408/jkv.v10i1.34258